Shopping Cart
- Remove All
- Your shopping cart is currently empty
Befotertinib (D-0316) mesylate, a third-generation EGFR tyrosine kinase inhibitor, is utilized in research focused on EGFR T790M-positive non-small cell lung cancer (NSCLC) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Befotertinib (D-0316) mesylate, a third-generation EGFR tyrosine kinase inhibitor, is utilized in research focused on EGFR T790M-positive non-small cell lung cancer (NSCLC) [1]. |
Alias | D-0316 mesylate |
Molecular Weight | 663.71 |
Formula | C30H36F3N7O5S |
Cas No. | 2226167-02-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.